Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedAug 17, 2026
DataAggregated Company Financials
Companies72
  • 7D14.5%
  • 3M56.7%
  • 1Y98.8%
  • YTD83.1%

In the last week, the Biotech industry is up 15%, with PharmaEssentia up 21%. During this same period, the ACRO Biomedical underperformed, falling 17%. This takes the industry's 12 month performance to a gain of 99%. As for the next few years, earnings are expected to grow by 51% per annum.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Aug 2026NT$1.1tNT$40.3b-NT$7,267,553,000.0027.9x-150.7x27.2x
Wed, 15 Jul 2026NT$978.0bNT$36.8b-NT$8,999,297,000.0028.7x-108.7x26.6x
Fri, 12 Jun 2026NT$736.2bNT$36.6b-NT$9,422,474,000.0027.2x-78.1x20.1x
Sun, 10 May 2026NT$656.4bNT$34.6b-NT$10,686,419,000.0028.7x-61.4x19x
Tue, 07 Apr 2026NT$630.8bNT$34.4b-NT$10,928,421,500.0028.8x-57.7x18.3x
Thu, 05 Mar 2026NT$656.0bNT$35.2b-NT$8,700,432,500.0029.6x-75.4x18.6x
Sat, 31 Jan 2026NT$701.2bNT$33.4b-NT$8,524,146,000.0029.4x-82.3x21x
Mon, 29 Dec 2025NT$567.4bNT$33.4b-NT$6,808,544,000.0029.6x-83.3x17x
Wed, 26 Nov 2025NT$543.6bNT$33.0b-NT$7,467,266,000.0037.5x-72.8x16.5x
Fri, 24 Oct 2025NT$554.8bNT$32.2b-NT$8,364,979,000.0035.1x-66.3x17.2x
Sun, 21 Sep 2025NT$549.2bNT$32.2b-NT$8,364,979,000.0035.2x-65.7x17x
Tue, 19 Aug 2025NT$515.1bNT$32.2b-NT$8,090,448,000.0041.2x-63.7x16x
Thu, 17 Jul 2025NT$502.0bNT$30.2b-NT$6,412,141,000.0036.5x-78.3x16.6x
Sat, 14 Jun 2025NT$507.0bNT$30.2b-NT$6,460,452,000.0037.7x-78.5x16.8x
Mon, 12 May 2025NT$497.0bNT$30.3b-NT$6,456,063,000.0037.4x-77x16.4x
Wed, 09 Apr 2025NT$437.7bNT$28.1b-NT$7,302,014,000.0027.7x-59.9x15.6x
Fri, 07 Mar 2025NT$545.1bNT$28.0b-NT$8,407,141,000.0033.6x-64.8x19.5x
Sun, 02 Feb 2025NT$550.6bNT$24.8b-NT$10,902,841,000.0034.9x-50.5x22.2x
Tue, 31 Dec 2024NT$509.9bNT$24.8b-NT$10,902,841,000.0034.2x-46.8x20.6x
Thu, 28 Nov 2024NT$507.5bNT$24.8b-NT$10,782,551,000.0037.7x-47.1x20.5x
Sat, 26 Oct 2024NT$545.1bNT$23.5b-NT$10,829,095,000.0039x-50.3x23.2x
Mon, 23 Sep 2024NT$579.7bNT$23.5b-NT$10,829,095,000.0035x-53.5x24.7x
Wed, 21 Aug 2024NT$569.0bNT$23.6b-NT$10,755,142,000.0034.4x-52.9x24.2x
Fri, 19 Jul 2024NT$579.6bNT$21.9b-NT$11,110,643,000.0044.6x-52.2x26.4x
Sun, 16 Jun 2024NT$513.1bNT$21.9b-NT$11,110,643,000.0042.7x-46.2x23.4x
Tue, 14 May 2024NT$454.6bNT$21.0b-NT$12,438,653,000.0034.5x-36.5x21.7x
Thu, 11 Apr 2024NT$463.3bNT$21.1b-NT$11,599,476,000.0051.7x-39.9x22x
Sat, 09 Mar 2024NT$436.2bNT$20.8b-NT$9,880,735,000.0038.8x-44.1x21x
Mon, 05 Feb 2024NT$435.3bNT$19.9b-NT$9,830,596,000.0039.3x-44.3x21.9x
Wed, 03 Jan 2024NT$473.1bNT$19.8b-NT$9,748,146,000.0039.6x-48.5x24x
Fri, 01 Dec 2023NT$485.5bNT$19.9b-NT$9,737,975,000.0043.1x-49.9x24.4x
Sun, 29 Oct 2023NT$472.4bNT$18.4b-NT$10,823,013,000.0051.5x-43.6x25.6x
Tue, 26 Sep 2023NT$482.7bNT$18.3b-NT$10,776,417,000.0043.7x-44.8x26.4x
Thu, 24 Aug 2023NT$479.5bNT$18.2b-NT$10,711,380,000.0041.9x-44.8x26.3x
Price to Earnings Ratio

-44.8x


Total Market Cap: NT$479.5bTotal Earnings: -NT$10,711,380,000.00Total Revenue: NT$18.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -60.8x202420252026
Current Industry PE
  • Investors are optimistic on the Taiwanese Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 21.0x is lower than the industry's current PS ratio of 27.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market3.58%
Healthcare6.75%
Biotech14.52%
Biotech14.52%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$1.41k6.0%
+NT$36.1b		246.4%PE76.6x
6696 Lin BioScienceNT$947.0031.5%
+NT$18.8b		499.4%PB7.3x
6949 Pell Bio-Med TechnologyNT$1.06k11.3%
+NT$6.9b		209.4%PS2363x
7920 Tripartite TherapeuticsNT$8.9012.7%
+NT$594.0m		n/an/a
4147 TaiMed BiologicsNT$61.601.0%
+NT$163.9m		-22.4%PS27.2x

Latest News

6949
NT$1,055.00
Pell Bio-Med Technology
7D
11.3%
1Y
209.4%
6492
NT$38.50
Senhwa Biosciences
7D
2.8%
1Y
3.5%
6547
NT$50.40
Medigen Vaccine Biologics
7D
-2.9%
1Y
27.3%
4147
NT$61.60
TaiMed Biologics
7D
1.0%
1Y
-22.4%
6712
NT$148.50
Ever Supreme Bio Technology
7D
-5.1%
1Y
0.3%
6446
NT$1,410.00
PharmaEssentia
7D
6.0%
1Y
246.4%
4162
NT$59.10
PharmaEngine
7D
-8.7%
1Y
-11.4%
6696
NT$947.00
Lin BioScience
7D
31.5%
1Y
499.4%
6617
NT$98.50
Gongwin Biopharm Holdings
7D
-6.6%
1Y
-3.9%
7924
NT$210.50
TLC BioSciences
7D
-8.5%
1Y
n/a
6945
NT$101.50
AP Biosciences
7D
-6.0%
1Y
-18.1%
6748
NT$187.00
ACRO Biomedical
7D
-4.1%
1Y
150.3%
6541
NT$37.30
Tanvex BioPharma
7D
-3.9%
1Y
-33.3%
4728
NT$385.50
Sunmax Biotechnology
7D
0.5%
1Y
-6.5%
7832
NT$12.15
Intelligene
7D
2.1%
1Y
21.5%